Skip to content

Clinical trials

Phase 3 Skin Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Skin Diseases Phase: Phase 3 Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20131
20151
20171
20182
20211
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
AbbVie (prior sponsor, Abbott)1
Akeso1
Binghe Xu1
Eli Lilly and Company1
LEO Pharma1
Novartis Pharmaceuticals1
Pfizer1
Shanghai Celgen Bio-Pharmaceutical Co.,Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Skin Diseases10
Psoriasis4
Breast Diseases2
Breast Neoplasms2
Eczema2
Neoplasm Metastasis2
Neoplasms by Site2
Pruritus2
Cellulitis1
Communicable Diseases1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.